FDA Import Refusal AEK-6283329-5/11/1 — Cipla Ltd.

Cipla Ltd. — FEI 3013070674

The FDA refused shipment AEK-6283329-5/11/1 from Cipla Ltd. (India) on Sep 5, 2019. The refused product falls under Drugs and Biologics — CLOMIPHENE CITRATE (GONAD-STIMULATING PRINCIPLE). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Sep 5, 2019
Country
India
Product Category
Drugs and Biologics
Product Code
64MBY01 CLOMIPHENE CITRATE (GONAD-STIMULATING PRINCIPLE)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.